BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Argus Health
Chinese Patent Office
Federal Trade Commission
Merck
AstraZeneca
Moodys
US Army
Julphar

Generated: January 18, 2018

DrugPatentWatch Database Preview

PARSIDOL Drug Profile

« Back to Dashboard

Which patents cover Parsidol, and what generic alternatives are available?

Parsidol is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in PARSIDOL is ethopropazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ethopropazine hydrochloride profile page.

US Patents and Regulatory Information for PARSIDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis PARSIDOL ethopropazine hydrochloride TABLET;ORAL 009078-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis PARSIDOL ethopropazine hydrochloride TABLET;ORAL 009078-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis PARSIDOL ethopropazine hydrochloride TABLET;ORAL 009078-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
AstraZeneca
Fuji
McKesson
Federal Trade Commission
Johnson and Johnson
Teva
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot